CN105561184A - Medicinal composition for activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, and preparation method thereof - Google Patents
Medicinal composition for activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, and preparation method thereof Download PDFInfo
- Publication number
- CN105561184A CN105561184A CN201511028229.7A CN201511028229A CN105561184A CN 105561184 A CN105561184 A CN 105561184A CN 201511028229 A CN201511028229 A CN 201511028229A CN 105561184 A CN105561184 A CN 105561184A
- Authority
- CN
- China
- Prior art keywords
- parts
- proportion
- radix
- add
- high speed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008280 blood Substances 0.000 title claims abstract description 48
- 210000004369 blood Anatomy 0.000 title claims abstract description 48
- 230000017531 blood circulation Effects 0.000 title claims abstract description 17
- 238000010792 warming Methods 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000000203 mixture Substances 0.000 title abstract description 7
- 230000003213 activating effect Effects 0.000 title abstract description 4
- 230000002040 relaxant effect Effects 0.000 title abstract 3
- 210000003462 vein Anatomy 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 14
- 239000009636 Huang Qi Substances 0.000 claims abstract description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 14
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 14
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 71
- 239000000706 filtrate Substances 0.000 claims description 50
- 239000000284 extract Substances 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000012141 concentrate Substances 0.000 claims description 34
- 108010059892 Cellulase Proteins 0.000 claims description 30
- 230000001737 promoting effect Effects 0.000 claims description 26
- 238000004108 freeze drying Methods 0.000 claims description 25
- 229940106157 cellulase Drugs 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 21
- -1 medical filtration Substances 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 20
- 239000000341 volatile oil Substances 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 229940088598 enzyme Drugs 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 15
- 238000007701 flash-distillation Methods 0.000 claims description 15
- 230000003020 moisturizing effect Effects 0.000 claims description 15
- 238000001256 steam distillation Methods 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 13
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 238000002390 rotary evaporation Methods 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 8
- 238000009413 insulation Methods 0.000 claims description 6
- 238000004821 distillation Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 16
- 230000007423 decrease Effects 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 7
- 206010019468 Hemiplegia Diseases 0.000 abstract description 4
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract description 4
- 230000036760 body temperature Effects 0.000 abstract description 3
- 238000001816 cooling Methods 0.000 abstract description 2
- 238000004090 dissolution Methods 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 238000002386 leaching Methods 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 231100000862 numbness Toxicity 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000008727 tongluo Substances 0.000 description 17
- 208000024172 Cardiovascular disease Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 11
- 208000026106 cerebrovascular disease Diseases 0.000 description 11
- 230000002526 effect on cardiovascular system Effects 0.000 description 11
- 210000002435 tendon Anatomy 0.000 description 10
- 208000007536 Thrombosis Diseases 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229960002275 pentobarbital sodium Drugs 0.000 description 4
- 206010008132 Cerebral thrombosis Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000027765 speech disease Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a medicinal composition for activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, and a preparation method thereof, and belongs to the field of traditional Chinese medicines. The medicinal composition comprises 260-300 parts of Ligusticum wallichii, 410-450 parts of Radix Astragali, 120-160 parts of panax notoginseng, 120-160 parts of cassia twig, 40-80 parts of Radix Aucklandiae, 120-160 parts of hawthorn fruit, 200-240 parts of Salvia miltiorrhiza, 120-160 parts of Rhizoma Alismatis, 40-80 parts of sophora flower, 120-160 parts of Radix Curcumae Aromaticae and 5-8 parts of borneol. The medicinal composition has the efficacy of activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, can be used to treat spirit dullness, hemiplegia, limb numbness, body cooling, unsmooth speech and other symptoms induced by cerebral thrombus and blood fat increase, and also has good effects on body temperature decrease, limb numbness and other symptoms; and a biological enzymatic hydrolysis, supercritical extraction, decoction and solvent normal temperature leaching technology combination extraction technology is adopted to extract raw materials with different qualities, so the dissolution of effective components of the medicines is greatly improved, and improvement of the quality of the above product is facilitated.
Description
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to one and there is blood circulation promoting and blood stasis dispelling, promoting the flow of QI in the collateral by warming the meridian function, is used for the treatment of cerebral thrombosis, blood fat increases that the dull mind, hemiplegia, numb limbs and tense tendons, the health that cause are sent out cool, the medicine and preparation method thereof of the speech disease such as puckery late.
Background technology
Cardiovascular and cerebrovascular disease is exactly that cardiovascular and cerebrovascular disease are referred to as, and makes a general reference because ischemic or hemorrhage occur for the heart that hyperlipemia, blood are sticky, atherosclerosis, hypertension etc. cause, brain and body tissue.There is the feature of " sickness rate is high, mortality rate is high, disability rate is high, complication is many, relapse rate high ", the minimal invasive treatment of cardiovascular and cerebrovascular disease takes care of oneself difficulty, economy and mental pressure large, patient through therapy rehabilitation is much lost work and viability, the number of cardiovascular and cerebrovascular disease is died from every year up to 1,500 ten thousand people in the whole world, on average within every six minutes, just there is a people to die from cardiovascular and cerebrovascular disease, become the number one killer threatening human health.Along with the increase of rhythm of life and pressure, the increase of unhealthy eating and lifestyle habits, cardiovascular and cerebrovascular disease more presents the trend of rejuvenation, extension, and at present, China has had suffers from cardiovascular and cerebrovascular disease more than 2.7 hundred million people.
The chemicals of current Cardiovarscular is more, but toxic side effect is large, dependency is strong, stimulate digestion and nervous system, be difficult to the shortcomings such as basic healing.Therefore the Chinese medicine of development of new blood circulation promoting and blood stasis dispelling, promoting the flow of QI in the collateral by warming the meridian is the important directions of Cardiovarscular.
Summary of the invention
The invention provides a kind of pharmaceutical composition for blood circulation promoting and blood stasis dispelling promoting the flow of QI in the collateral by warming the meridian and preparation method thereof, be used for the treatment of cerebral thrombosis, blood fat increase that the dull mind, hemiplegia, numb limbs and tense tendons, the health that cause are sent out cool, the speech symptom such as puckery late, wherein Chinese medicine composition of the present invention (XIAOSHUAN TONGLUO PIAN) has good effect to the symptom such as temperature decline, numb limbs and tense tendons
The many relations from gas and blood of theory of Chinese medical science explain cardiovascular and cerebrovascular disease, qi depression to blood stasis, and negative and positive of qi and blood disorder imbalance is the major reason causing cardiovascular and cerebrovascular disease.Theory of Chinese medical science have " qi as the commander of blood ", saying of " blood being gas internal organs ", what the former said is the effect of gas to blood, i.e. qi promoting blood production, QI can promote blood circulation, QI can control blood three parts, the nutrient substance of human consumption or smart unit are converted to the effect all be unableing to do without gas of blood, are again the power of blood with seasonal epidemic pathogens, " gas is capable is blood flow " is recorded in " generation of Plain Questions the five internal organs ", QI movement being in harmonious way, blood could be normal, so-called " stagnation of QI is blood stasis then "; Astringency inducing effect with seasonal epidemic pathogens makes blood not overflow outside venation, as said in " treatise on blood trouble pathogenesis of Zong-Fu diseases opinion " " life of the person, in a word with gas system blood "; " blood is gas internal organs " refers to the effect of blood to gas, comprise blood energy anger, blood can carry QI, namely the generation providing gas by blood and the nutrient substance played needed for physiological function, it is the source of nutrition of gas, gas arrives whole body, and each is realized by the delivery of blood through normal pulse organ, as described in " symposium on medical topics 30 sections ": " gas sun and blood is cloudy, blood is not only, and bad gas is with life; Gas without appended, rely blood with attached it ", blood can also suppress laxing of gas not received as can be seen here.Through QI-insufficiency, hematogenous blockage, will inevitably cause venation block, and then forms thromboembolism.Although some XIAOSHUAN TONGLUO PIAN of selling on the market at present it is reported can to cardiovascular and cerebrovascular disease curative effect to some extent, but in all reports of the research about XIAOSHUAN TONGLUO PIAN, almost do not mention the symptoms such as its temperature decline caused cardiovascular and cerebrovascular disease, numb limbs and tense tendons to possess some special knowledge and effect, and temperature decline seriously can cause human chitinase vigor to change, metabolic function is disorderly, and numb limbs and tense tendons can cause patient handicapped especially, difficulty of taking care of oneself, psychological burden increases the weight of
The Chinese medicine composition that the present invention relates to reuses Radix Notoginseng, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Fructus Crataegi, get that its activating QI to alleviate the depression, method wind-dryness are wet, dissipating blood stasis hemostasis, subduing swelling and relieving pain, removing heat from blood eliminating carbuncle effect, the blood pressure lowering of Flos Sophorae removing heat from blood, Radix Curcumae promoting QI circulation for relieving depression, Radix Aucklandiae spleen invigorating intestinal stasis relieving, Borneolum Syntheticum removing heat from the heart to restore the consciousness are the ministerial drug of auxiliary monarch altogether, more be equipped with that Rhizoma Alismatis dehumidifying expels the heat-evil, Ramulus Cinnamomi complement sun, logical blood warm up spleen, Radix Astragali consolidating superficial resistance QI invigorating, altogether for Fang Zhongzuo makes, all medicines share blood circulation promoting and blood stasis dispelling, promoting the flow of QI in the collateral by warming the meridian.
The technical scheme that the present invention takes is: be made up of the raw material of following parts by weight:
Rhizoma Chuanxiong 260-300 part, Radix Astragali 410-450 part, Radix Notoginseng 120-160 part, Ramulus Cinnamomi 120-160 part, Radix Aucklandiae 40-80 part, Fructus Crataegi 120-160 part, Radix Salviae Miltiorrhizae 200-240 part, Rhizoma Alismatis 120-160 part, Flos Sophorae 40-80 part, Radix Curcumae 120-160 part, Borneolum Syntheticum 5-8 part.
Preferred:
Rhizoma Chuanxiong 280 parts, the Radix Astragali 430 parts, Radix Notoginseng 140 parts, Ramulus Cinnamomi 140 parts, the Radix Aucklandiae 60 parts, Fructus Crataegi 140 parts, Radix Salviae Miltiorrhizae 220 parts, Rhizoma Alismatis 140 parts, 60 parts, Flos Sophorae, Radix Curcumae 140 parts, Borneolum Syntheticum 6.5 parts
The preparation method of pharmaceutical composition effective ingredient of the present invention comprises the following steps:
(1) get Rhizoma Chuanxiong in proportion, add the compound enzyme containing cellulase and pectase of 1%-10%, add the warm water of 1-10 times amount, mixing, 40-60 DEG C of insulation enzymolysis 1-5 hour; Moisturizing, use steam distillation to extract 1-5 time, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(2) get the Radix Astragali in proportion, add the compound enzyme containing cellulase and pectase of 1%-10%, add the warm water of 1-10 times amount, mixing, 40-60 DEG C of insulation enzymolysis 1-5 hour; Moisturizing, use steam distillation to extract 1-5 time, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(3) get Radix Notoginseng in proportion, the ethanol adding 1-50 times of 10%-99% extracts, and each 1-5 hour extracts 1-5 time, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(4) get Ramulus Cinnamomi in proportion, add 1-25 soak by water doubly 1-5 time, each 1-5 hour, use high speed centrifuge centrifugal, filter, merging filtrate also concentrates to obtain extractum;
(5) get the Radix Aucklandiae in proportion, be ground into coarse powder, add 1-10 times of warm water, within vapor distillation 1-20 hour, extract volatile oil, lyophilization, for subsequent use;
(6) get Fructus Crataegi in proportion, add the compound enzyme containing cellulase and pectase of 1%-10%, add the warm water of 1-10 times amount, mixing, 40-60 DEG C of insulation enzymolysis 1-5 hour; Moisturizing, use steam distillation extracts 1-5 time, collects volatile oil, medical filtration, and filtrate merges, and after using flash distillation instrument to concentrate, adds ethanol hold over night, uses high speed centrifuge centrifugal, filters, and reclaims filtrate and concentrates to obtain extractum;
(7) get Radix Salviae Miltiorrhizae in proportion, add 1-25 soak by water doubly 1-5 time, each 1-5 hour, use high speed centrifuge centrifugal, filter, merging filtrate also concentrates to obtain extractum;
(8) get Rhizoma Alismatis in proportion, the ethanol adding 1-50 times of 10%-99% extracts, and each 1-5 hour extracts 1-5 time, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(9) get Flos Sophorae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 1-10%, extracting pressure 5-40MPa, temperature 10-50 DEG C, CO
2flow 1-5ml/g crude drug min, extraction time 100-180min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
(10) get Radix Curcumae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 1-10%, extracting pressure 5-40MPa, temperature 10-50 DEG C, CO
2flow 1-5ml/g crude drug min, extraction time 100-180min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
Use closed pulverizer to be pulverized by above-mentioned substance, add Borneolum Syntheticum mixing, use rotary tablet machine to be pressed into the tablet of 0.38g/ sheet.
The ratio of step of the present invention (one) compound enzyme cellulase and pectase is 1:1.
The ratio of step of the present invention (two) compound enzyme cellulase and pectase is 1:1.
The ratio of step of the present invention (six) compound enzyme cellulase and pectase is 1:1.
The present invention has blood circulation promoting and blood stasis dispelling, effect of promoting the flow of QI in the collateral by warming the meridian, can be used for treating that cerebral thrombosis, blood fat increase that the dull mind, hemiplegia, numb limbs and tense tendons, the health that cause are sent out cool, the speech symptom such as puckery late, also have good effect to the symptom such as temperature decline, numb limbs and tense tendons; And adopt biological enzymolysis respectively, supercritical extraction according to raw material quality difference, decoct, the leach extraction method that the technological means such as solvent room temperature leaching combine, substantially increases the dissolution of effective ingredient, is conducive to the raising of product quality.
Detailed description of the invention
Embodiment 1
Be made up of the raw material of following parts by weight:
Rhizoma Chuanxiong 260 parts, the Radix Astragali 410 parts, Radix Notoginseng 120 parts, Ramulus Cinnamomi 120 parts, the Radix Aucklandiae 40 parts, Fructus Crataegi 120 parts, Radix Salviae Miltiorrhizae 200 parts, Rhizoma Alismatis 120 parts, 40 parts, Flos Sophorae, Radix Curcumae 120, Borneolum Syntheticum 5 parts;
The preparation method of pharmaceutical composition effective ingredient of the present invention comprises the following steps:
(1) get Rhizoma Chuanxiong in proportion, add the compound enzyme containing cellulase and pectase of 1%, the ratio of its cellulase and pectase is 1:1, adds the warm water of 1 times amount, mixing, and 40 DEG C are incubated enzymolysis 1 hour; Moisturizing, use steam distillation to extract 1 time, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(2) get the Radix Astragali in proportion, add the compound enzyme containing cellulase and pectase of 1%, the ratio of its cellulase and pectase is 1:1, adds the warm water of 1 times amount, mixing, and 40 DEG C are incubated enzymolysis 1 hour; Moisturizing, use steam distillation to extract 1 time, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(3) get Radix Notoginseng in proportion, the ethanol adding 1 times 10% extracts, each 1 hour, extracts 1 time, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(4) get Ramulus Cinnamomi in proportion, add the soak by water 1 time of 1 times, each 1 hour, use high speed centrifuge centrifugal, filter, merging filtrate also concentratedly to obtain extractum;
(5) get the Radix Aucklandiae in proportion, be ground into coarse powder, add 1 times of warm water, vapor distillation extracts volatile oil, lyophilization in 1 hour, for subsequent use;
(6) get Fructus Crataegi in proportion, add the compound enzyme containing cellulase and pectase of 1%, the ratio of its cellulase and pectase is 1:1, adds the warm water of 1 times amount, mixing, and 40 DEG C are incubated enzymolysis 1 hour; Moisturizing, use steam distillation to extract 1 time, collect volatile oil, medical filtration, filtrate merges, and after using flash distillation instrument to concentrate, adds ethanol hold over night, uses high speed centrifuge centrifugal, filters, and reclaims filtrate and concentrates to obtain extractum;
(7) get Radix Salviae Miltiorrhizae in proportion, add the soak by water 1 time of 1 times, each 1 hour, use high speed centrifuge centrifugal, filter, merging filtrate also concentratedly to obtain extractum;
(8) get Rhizoma Alismatis in proportion, the ethanol adding 1 times 10% extracts, each 1 hour, extracts 1 time, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(9) get Flos Sophorae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 1%, extracting pressure 5MPa, temperature 10 DEG C, CO
2flow 1ml/g crude drug min, extraction time 100min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
(10) get Radix Curcumae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 1%, extracting pressure 5MPa, temperature 10 DEG C, CO
2flow 1ml/g crude drug min, extraction time 100min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
Use closed pulverizer to be pulverized by above-mentioned substance, add Borneolum Syntheticum mixing, use rotary tablet machine to be pressed into the tablet of 0.38g/ sheet.
Embodiment 2
Be made up of the raw material of following parts by weight:
Rhizoma Chuanxiong 280 parts, the Radix Astragali 430 parts, Radix Notoginseng 140 parts, Ramulus Cinnamomi 140 parts, the Radix Aucklandiae 60 parts, Fructus Crataegi 140 parts, Radix Salviae Miltiorrhizae 220 parts, Rhizoma Alismatis 140 parts, 60 parts, Flos Sophorae, Radix Curcumae 140 parts, Borneolum Syntheticum 6.5 parts.
The preparation method of pharmaceutical composition effective ingredient of the present invention comprises the following steps:
(1) get Rhizoma Chuanxiong in proportion, add the compound enzyme containing cellulase and pectase of 5.5%, the ratio of its cellulase and pectase is 1:1, adds the warm water of 5.5 times amount, mixing, and 50 DEG C are incubated enzymolysis 3 hours; Moisturizing, use steam distillation to extract 3 times, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(2) get the Radix Astragali in proportion, add the compound enzyme containing cellulase and pectase of 5.5%, the ratio of its cellulase and pectase is 1:1, adds the warm water of 5.5 times amount, mixing, and 50 DEG C are incubated enzymolysis 3 hours; Moisturizing, use steam distillation to extract 3 times, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(3) get Radix Notoginseng in proportion, the ethanol adding 25 times 55% extracts, each 3 hours, extracts 3 times, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(4) get Ramulus Cinnamomi in proportion, add the soak by water 3 times of 13 times, each 3 hours, use high speed centrifuge centrifugal, filter, merging filtrate also concentratedly to obtain extractum;
(5) get the Radix Aucklandiae in proportion, be ground into coarse powder, add 5.5 times of warm water, vapor distillation extracts volatile oil, lyophilization in 10.5 hours, for subsequent use;
(6) get Fructus Crataegi in proportion, add the compound enzyme containing cellulase and pectase of 5.5%, the ratio of its cellulase and pectase is 1:1, adds the warm water of 5.5 times amount, mixing, and 50 DEG C are incubated enzymolysis 3 hours; Moisturizing, use steam distillation to extract 3 times, collect volatile oil, medical filtration, filtrate merges, and after using flash distillation instrument to concentrate, adds ethanol hold over night, uses high speed centrifuge centrifugal, filters, and reclaims filtrate and concentrates to obtain extractum;
(7) get Radix Salviae Miltiorrhizae in proportion, add the soak by water 3 times of 13 times, each 3 hours, use high speed centrifuge centrifugal, filter, merging filtrate also concentratedly to obtain extractum;
(8) get Rhizoma Alismatis in proportion, the ethanol adding 25 times 55% extracts, each 3 hours, extracts 3 times, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(9) get Flos Sophorae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 5.5%, extracting pressure 22MPa, temperature 30 DEG C, CO
2flow 3ml/g crude drug min, extraction time 140min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
(10) get Radix Curcumae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 5.5%, extracting pressure 22MPa, temperature 30 DEG C, CO
2flow 3ml/g crude drug min, extraction time 140min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
Use closed pulverizer to be pulverized by above-mentioned substance, add Borneolum Syntheticum mixing, use rotary tablet machine to be pressed into the tablet of 0.38g/ sheet.
Embodiment 3
Be made up of the raw material of following parts by weight:
Rhizoma Chuanxiong 300 parts, the Radix Astragali 450 parts, Radix Notoginseng 160 parts, Ramulus Cinnamomi 160 parts, the Radix Aucklandiae 80 parts, Fructus Crataegi 160 parts, Radix Salviae Miltiorrhizae 240 parts, Rhizoma Alismatis 160 parts, 80 parts, Flos Sophorae, Radix Curcumae 160 parts, Borneolum Syntheticum 8 parts;
The preparation method of pharmaceutical composition effective ingredient of the present invention comprises the following steps:
(1) get Rhizoma Chuanxiong in proportion, add the compound enzyme containing cellulase and pectase of 10%, the ratio of its cellulase and pectase is 1:1, adds the warm water of 10 times amount, mixing, and 60 DEG C are incubated enzymolysis 5 hours; Moisturizing, use steam distillation to extract 5 times, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(2) get the Radix Astragali in proportion, add the compound enzyme containing cellulase and pectase of 10%, the ratio of its cellulase and pectase is 1:1, adds the warm water of 10 times amount, mixing, and 60 DEG C are incubated enzymolysis 5 hours; Moisturizing, use steam distillation to extract 5 times, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(3) get Radix Notoginseng in proportion, the ethanol adding 50 times 99% extracts, each 5 hours, extracts 5 times, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(4) get Ramulus Cinnamomi in proportion, add the soak by water 5 times of 25 times, each 5 hours, use high speed centrifuge centrifugal, filter, merging filtrate also concentratedly to obtain extractum;
(5) get the Radix Aucklandiae in proportion, be ground into coarse powder, add 10 times of warm water, vapor distillation extracts volatile oil, lyophilization in 20 hours, for subsequent use;
(6) get Fructus Crataegi in proportion, add the compound enzyme containing cellulase and pectase of 10%, the ratio of its cellulase and pectase is 1:1, adds the warm water of 10 times amount, mixing, and 60 DEG C are incubated enzymolysis 5 hours; Moisturizing, use steam distillation to extract 5 times, collect volatile oil, medical filtration, filtrate merges, and after using flash distillation instrument to concentrate, adds ethanol hold over night, uses high speed centrifuge centrifugal, filters, and reclaims filtrate and concentrates to obtain extractum;
(7) get Radix Salviae Miltiorrhizae in proportion, add the soak by water 5 times of 25 times, each 5 hours, use high speed centrifuge centrifugal, filter, merging filtrate also concentratedly to obtain extractum;
(8) get Rhizoma Alismatis in proportion, the ethanol adding 50 times 99% extracts, each 5 hours, extracts 5 times, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(9) get Flos Sophorae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 10%, extracting pressure 40MPa, temperature 50 C, CO
2flow 5ml/g crude drug min, extraction time 180min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
(10) get Radix Curcumae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 10%, extracting pressure 40MPa, temperature 50 C, CO
2flow 5ml/g crude drug min, extraction time 180min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
Use closed pulverizer to be pulverized by above-mentioned substance, add Borneolum Syntheticum mixing, use rotary tablet machine to be pressed into the tablet of 0.38g/ sheet.
Effect of the present invention is further illustrated below by pharmacodynamic experiment.
1 experiment material
1.1 laboratory animal
Kun Ming mice, body weight 18-22g, male and female half and half, are provided by Jilin University's biotic experiment center.
1.2 experimental drug
Medicine of the present invention, hereinafter referred to as XIAOSHUAN TONGLUO PIAN, is provided by JiLin ZiXin Pharmacy Co., Ltd
Pentobarbital sodium, by Beijing, Pu Bosi bio tech ltd provides
Normal saline, medical alcohol, distilled water
1.3 experiment equipment
Scalpel, surgical scissors, clinical thermometer, surgeon's knot binding, injector for medical purpose, mice rotation test system (revolving excellent instrument), electronic analytical balance, mouse stomach pin, volumetric flask, Glass rod, beaker, graduated cylinder
2 test methods and result
120 Kun Ming mice are bought from Jilin University's biotic experiment center, male and female half and half, each 18-22g, physical health, action is active, room temperature 25 DEG C, raise in the Mouse feeder laboratory of relative humidity 50%-60%, use special feed and water to feed, illumination every day and interlunation half and half, ad lib drinking-water one week, to conform.Study from mouse temperature, reaction sensitivity (numb limbs and tense tendons), thrombosis length three aspects.Experimental data represents with mean ± standard deviation (x ± s), and between employing group, statistical analysis is carried out in t inspection.
2.1 XIAOSHUAN TONGLUO PIAN are on the impact of mouse temperature
Get 40 healthy mices, male and female half and half, be respectively blank group, the basic, normal, high dosage group of XIAOSHUAN TONGLUO PIAN, often organize ten, male and female half and half, press table 1 dosage gastric infusion respectively, blank group uses distilled water gavage, successive administration five days, lumbar injection 50mg/ml pentobarbital sodium is anaesthetized, surgical ligation postcava, sew up after 5 hours, test mice anus body temperature.
Table 1 XIAOSHUAN TONGLUO PIAN is on the impact of mouse temperature
| Group | Mice quantity | Drug dose (g/kg) | Body temperature |
| Matched group | 10 | - | 36.02±0.52 |
| Low dose group | 10 | 3 | 36.29±0.50 ** |
| Middle dosage group | 10 | 6 | 36.52±0.66 ** |
| High dose group | 10 | 12 | 36.80±0.86 ** |
Note: compare with negative control, * P<0.05, * * P<0.01
Known by experiment, the effect of the temperature decline that XIAOSHUAN TONGLUO PIAN has significantly treatment thrombosis to cause.
2.2 XIAOSHUAN TONGLUO PIAN are on the impact of mice reaction sensitivity
Get 40 healthy mices, male and female half and half, be respectively blank group, the basic, normal, high dosage group of XIAOSHUAN TONGLUO PIAN, often organize ten, male and female half and half, press table 2 dosage gastric infusion respectively, blank group uses distilled water gavage, successive administration five days, lumbar injection 50mg/ml pentobarbital sodium is anaesthetized, surgical ligation postcava, sew up after 5 hours, use and revolve excellent instrument test mice reaction sensitivity.
Table 2 XIAOSHUAN TONGLUO PIAN is on the impact of mice reaction sensitivity
Note: compare with negative control, * P<0.05, * * P<0.01
Known by experiment, the effect of the numb limbs and tense tendons that XIAOSHUAN TONGLUO PIAN has treatment thrombosis to cause.
2.3 XIAOSHUAN TONGLUO PIAN are on the impact of mice thrombosis length
Get 40 healthy mices, male and female half and half, be respectively blank group, the basic, normal, high dosage group of XIAOSHUAN TONGLUO PIAN, often organizes ten, male and female half and half, press table 3 dosage gastric infusion respectively, blank group uses distilled water gavage, successive administration five days, lumbar injection 50mg/ml pentobarbital sodium is anaesthetized, and surgical ligation postcava, sewed up after 10 hours, again surgical incision abdominal cavity, removal of thromboses is numbered, and weighs weight in wet base, be placed in 50 DEG C of baking ovens again to dry, after cooling, weigh dry weight.
Table 3 XIAOSHUAN TONGLUO PIAN is on the impact of mice reaction sensitivity
Note: compare with negative control, * P<0.05, * * P<0.01
Known by experiment, XIAOSHUAN TONGLUO PIAN has effect of inhibition thrombosis and expansion.
Prove by experiment, Chinese medicine composition XIAOSHUAN TONGLUO PIAN of the present invention has inhibition thrombosis and development and treats effect such as temperature decline, numb limbs and tense tendons that thrombosis causes.
Claims (6)
1. for a pharmaceutical composition for blood circulation promoting and blood stasis dispelling promoting the flow of QI in the collateral by warming the meridian, it is characterized in that: be made up of the raw material of following parts by weight:
Rhizoma Chuanxiong 260-300 part, Radix Astragali 410-450 part, Radix Notoginseng 120-160 part, Ramulus Cinnamomi 120-160 part, Radix Aucklandiae 40-80 part, Fructus Crataegi 120-160 part, Radix Salviae Miltiorrhizae 200-240 part, Rhizoma Alismatis 120-160 part, Flos Sophorae 40-80 part, Radix Curcumae 120-160 part, Borneolum Syntheticum 5-8 part.
2. a kind of pharmaceutical composition for blood circulation promoting and blood stasis dispelling promoting the flow of QI in the collateral by warming the meridian according to claim 1, is characterized in that: be made up of the raw material of following parts by weight:
Rhizoma Chuanxiong 280 parts, the Radix Astragali 430 parts, Radix Notoginseng 140 parts, Ramulus Cinnamomi 140 parts, the Radix Aucklandiae 60 parts, Fructus Crataegi 140 parts, Radix Salviae Miltiorrhizae 220 parts, Rhizoma Alismatis 140 parts, 60 parts, Flos Sophorae, Radix Curcumae 140 parts, Borneolum Syntheticum 6.5 parts.
3. the preparation method of a kind of pharmaceutical composition for blood circulation promoting and blood stasis dispelling promoting the flow of QI in the collateral by warming the meridian as claimed in claim 1 or 2, is characterized in that comprising the following steps:
(1) get Rhizoma Chuanxiong in proportion, add the compound enzyme containing cellulase and pectase of 1%-10%, add the warm water of 1-10 times amount, mixing, 40-60 DEG C of insulation enzymolysis 1-5 hour; Moisturizing, use steam distillation to extract 1-5 time, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(2) get the Radix Astragali in proportion, add the compound enzyme containing cellulase and pectase of 1%-10%, add the warm water of 1-10 times amount, mixing, 40-60 DEG C of insulation enzymolysis 1-5 hour; Moisturizing, use steam distillation to extract 1-5 time, collect volatile oil, medical filtration, filtrate merges, and after use flash distillation instrument is concentrated, adds a large amount of ethanol hold over night, uses high speed centrifuge centrifugal, then filters, and reclaims filtrate and concentrates to obtain extractum;
(3) get Radix Notoginseng in proportion, the ethanol adding 1-50 times of 10%-99% extracts, and each 1-5 hour extracts 1-5 time, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(4) get Ramulus Cinnamomi in proportion, add 1-25 soak by water doubly 1-5 time, each 1-5 hour, use high speed centrifuge centrifugal, filter, merging filtrate also concentrates to obtain extractum;
(5) get the Radix Aucklandiae in proportion, be ground into coarse powder, add 1-10 times of warm water, within vapor distillation 1-20 hour, extract volatile oil, lyophilization, for subsequent use;
(6) get Fructus Crataegi in proportion, add the compound enzyme containing cellulase and pectase of 1%-10%, add the warm water of 1-10 times amount, mixing, 40-60 DEG C of insulation enzymolysis 1-5 hour; Moisturizing, use steam distillation extracts 1-5 time, collects volatile oil, medical filtration, and filtrate merges, and after using flash distillation instrument to concentrate, adds ethanol hold over night, uses high speed centrifuge centrifugal, filters, and reclaims filtrate and concentrates to obtain extractum;
(7) get Radix Salviae Miltiorrhizae in proportion, add 1-25 soak by water doubly 1-5 time, each 1-5 hour, use high speed centrifuge centrifugal, filter, merging filtrate also concentrates to obtain extractum;
(8) get Rhizoma Alismatis in proportion, the ethanol adding 1-50 times of 10%-99% extracts, and each 1-5 hour extracts 1-5 time, and use high speed centrifuge centrifugal, filter, merging filtrate concentrates, and grinds powdered after lyophilization, for subsequent use;
(9) get Flos Sophorae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 1-10%, extracting pressure 5-40MPa, temperature 10-50 DEG C, CO
2flow 1-5m1/g crude drug min, extraction time 100-180min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
(10) get Radix Curcumae in proportion, join CO
2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 1-10%, extracting pressure 5-40MPa, temperature 10-50 DEG C, CO
2flow 1-5m1/g crude drug min, extraction time 100-180min, obtains supercritical extract, concentrated by rotary evaporation, lyophilization;
Use closed pulverizer to be pulverized by above-mentioned substance, add Borneolum Syntheticum mixing, use rotary tablet machine to be pressed into the tablet of 0.38g/ sheet.
4. the preparation method of a kind of pharmaceutical composition for blood circulation promoting and blood stasis dispelling promoting the flow of QI in the collateral by warming the meridian according to claim 3, is characterized in that: the ratio of described step (one) compound enzyme cellulase and pectase is 1:1.
5. the preparation method of a kind of pharmaceutical composition for blood circulation promoting and blood stasis dispelling promoting the flow of QI in the collateral by warming the meridian according to claim 3, is characterized in that: the ratio of described step (two) compound enzyme cellulase and pectase is 1:1.
6. the preparation method of a kind of pharmaceutical composition for blood circulation promoting and blood stasis dispelling promoting the flow of QI in the collateral by warming the meridian according to claim 3, is characterized in that: the ratio of described step (six) compound enzyme cellulase and pectase is 1:1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511028229.7A CN105561184A (en) | 2015-12-31 | 2015-12-31 | Medicinal composition for activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511028229.7A CN105561184A (en) | 2015-12-31 | 2015-12-31 | Medicinal composition for activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105561184A true CN105561184A (en) | 2016-05-11 |
Family
ID=55872192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201511028229.7A Withdrawn CN105561184A (en) | 2015-12-31 | 2015-12-31 | Medicinal composition for activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105561184A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108066702A (en) * | 2016-11-29 | 2018-05-25 | 陕西步长制药有限公司 | A kind of Chinese medicine preparation for treating syndrome of blood stasis due to qi deficiency and preparation method thereof |
| CN108552495A (en) * | 2017-12-12 | 2018-09-21 | 常州金艺广告传媒有限公司 | A kind of preparation method of blood-circulation and removing blood stasis ointment |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103495117A (en) * | 2013-10-09 | 2014-01-08 | 南京正亮医药科技有限公司 | Preparation method and application of thrombus removing and collaterals dredging tablets |
| CN104856968A (en) * | 2015-05-27 | 2015-08-26 | 韩志强 | Traditional Chinese medicine tablet with effects of removing thrombus and dredging collaterals and preparation method thereof |
-
2015
- 2015-12-31 CN CN201511028229.7A patent/CN105561184A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103495117A (en) * | 2013-10-09 | 2014-01-08 | 南京正亮医药科技有限公司 | Preparation method and application of thrombus removing and collaterals dredging tablets |
| CN104856968A (en) * | 2015-05-27 | 2015-08-26 | 韩志强 | Traditional Chinese medicine tablet with effects of removing thrombus and dredging collaterals and preparation method thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108066702A (en) * | 2016-11-29 | 2018-05-25 | 陕西步长制药有限公司 | A kind of Chinese medicine preparation for treating syndrome of blood stasis due to qi deficiency and preparation method thereof |
| CN108066702B (en) * | 2016-11-29 | 2020-04-14 | 陕西步长制药有限公司 | Traditional Chinese medicine preparation for treating qi deficiency and blood stasis syndrome and preparation method thereof |
| CN108552495A (en) * | 2017-12-12 | 2018-09-21 | 常州金艺广告传媒有限公司 | A kind of preparation method of blood-circulation and removing blood stasis ointment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101810685B (en) | Chinese medicinal composition for treating gonitis and preparation method thereof | |
| CN1994451B (en) | Chinese medicinal composition for treating depression, its preparation method and application | |
| CN101856482B (en) | Pure Chinese medicinal preparation for treating mental illness and preparation method thereof | |
| CN102166278B (en) | Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof | |
| CN105561214A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104666579A (en) | Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method of traditional Chinese medicine composition | |
| CN104689226A (en) | Traditional Chinese medicine composition for treating children with rheumatoid arthritis and preparation method thereof | |
| CN104825914A (en) | Traditional Chinese medicinal preparation for assisted treatment of breast cancer | |
| CN104940868A (en) | Traditional Chinese medicine formula for treating cervical spondylosis, and cervical vertebra paste | |
| CN102145057A (en) | Antispasmodic traditional Chinese medicine composition and preparation method thereof | |
| CN105561184A (en) | Medicinal composition for activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, and preparation method thereof | |
| CN104548049A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
| CN104547598A (en) | Traditional Chinese medicine preparation for treating neurasthenia and preparation method thereof | |
| CN103920058A (en) | Traditional Chinese medicine preparation for treating headache and preparation method thereof | |
| CN104623583A (en) | Asthenia cold abdominalgia treating drug and preparation method of asthenia cold abdominalgia treating drug oral liquid | |
| CN102743703A (en) | Medicament for treating cervical spondylosis and preparation method thereof | |
| CN103285328B (en) | Traditional Chinese medicine composition capsule for treating coronary heart diseases and preparation method thereof | |
| CN101708230B (en) | Anti-drug medicine and preparation method thereof | |
| CN104857370A (en) | Traditional Chinese medicine composition for treating breast cancer | |
| CN105031550A (en) | Novel traditional Chinese medicine formula for tumor treatment containing scorpion venom macromolecules | |
| CN101181608B (en) | Medicine for giving up drug | |
| CN104258351A (en) | Traditional Chinese medicine preparation for treating alcoholic cardiomyopathy and preparation method of preparation | |
| CN108853340A (en) | A kind of Chinese medicine of nourishing the liver and kidney and preparation method thereof | |
| CN103285327B (en) | Traditional Chinese medicine composition tablet for treating coronary heart diseases and preparation method thereof | |
| CN103330911B (en) | Chinese medicine powder for treating coronary heart disease and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160511 |
|
| WW01 | Invention patent application withdrawn after publication |